What to expect: Cross-class switch + cross-indication. Wegovy is for obesity, Mounjaro is for T2D. Restart titration from Mounjaro 2.5 mg. Coverage verification critical.
Washout window: ~7 days for Wegovy to clear
Why patients switch from Wegovy to Mounjaro
- Type 2 diabetes diagnosis — Mounjaro is the T2D-indicated tirzepatide
- Greater weight-loss expectations on tirzepatide
- Insurance covers Mounjaro but not Wegovy
- Wegovy shortage 2022-2024
- Plateau on Wegovy at max dose 2.4 mg
Side effects during the Wegovy → Mounjaro transition
- Nausea increase
- Constipation
- Temporary appetite return
- A1C may fluctuate during titration if T2D present
Discuss with your prescriber before switching
This guide is editorial — not medical advice. Switching GLP-1 medications must be supervised. Bring this checklist to your appointment:
- Required — verify T2D diagnosis for Mounjaro coverage
- If on insulin (hypoglycemia risk)
- If history of medullary thyroid cancer (contraindication)
Dose conversion: Wegovy → Mounjaro
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Wegovy dose | Mounjaro dose | Note |
|---|---|---|
| Any | Restart titration from lowest dose | Different mechanism (semaglutide → tirzepatide). No direct conversion. |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (semaglutide → tirzepatide), insurance implications.
Week −1: Last Wegovy dose
Continue your current Wegovy schedule. Wegovy has a long half-life — semaglutide ~1 week, tirzepatide ~5 days — so effects persist for days after stopping.
Week 0: First Mounjaro dose
Restart titration from lowest Mounjaro dose. Overlap effect possible in the first 7-10 days as Wegovy clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. GI symptoms (nausea, constipation) may be more pronounced. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Wegovy baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Wegovy, discuss reverting or trying a third option (often semaglutide-based).
FAQ — Wegovy → Mounjaro
Can I take Wegovy and Mounjaro together?
No. Combining GLP-1 medications isn't done outside clinical trials. Stop Wegovy before starting Mounjaro; the long half-lives mean overlap occurs naturally.
Will I lose ground when switching from Wegovy to Mounjaro?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Wegovy efficacy. Plan and 12-week evaluation window.
Does insurance cover Mounjaro if it covered Wegovy?
Different molecule means different formulary placement. Run a fresh prior authorization for Mounjaro — coverage of Wegovy doesn't transfer automatically.
How long does Wegovy stay in my system after the last dose?
Semaglutide has a ~1-week half-life — effects taper over 4-5 weeks after the last injection. Plan your Mounjaro start timing accordingly.
Cost comparison
Cash-pay pricing differs significantly between Wegovy and Mounjaro. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Mounjaro
Continuity of care matters during a switch. We compared 12+ telehealth providers ranked by Mounjaro availability, price, and prescriber accessibility.
See top Mounjaro providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Wegovy review and Mounjaro review. For provider options that carry both medications, see our Wegovy vs Mounjaro comparison and Wegovy alternatives hub.
Sources
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.